Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study)

Hum Vaccin Immunother. 2022 Dec 31;18(1):2024065. doi: 10.1080/21645515.2021.2024065. Epub 2022 Feb 1.

Abstract

Human Papillomavirus (HPV) is one of the most common sexually transmitted infections associated with a wide range of diseases and cancers that may affect both genders. Since 2007, the Spanish National Immunization Program includes HPV vaccination, and currently it only targets 12-year-old girls. The objective of our study is to assess differences in the knowledge of HPV and HPV vaccine acceptability according to different factors, and to identify the role of different sources of information. A cross-sectional, multicenter survey research was carried out in twenty-four pediatric offices in Spain, and included parents of children aged 9 to 14 years old. 1,405 valid survey-responses were considered for the analysis. Parental awareness of HPV and HPV vaccine, as well as vaccine acceptability, are still strongly associated with child gender (girls) and age (12-14 years old). HPV knowledge and HPV vaccine acceptability are related to parental gender, HPV vaccination status and having at least one daughter. Parents who consulted a healthcare source to obtain further information about HPV had greater HPV and HPV vaccine knowledge and acceptability. HPV and HPV vaccine awareness and acceptability are strongly associated with child gender and age, which correlates with the current immunization program.

Keywords: HPV; HPV vaccine; HPV-related diseases; acceptability; adolescent; factors; information source; knowledge; parents; vaccination.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alphapapillomavirus*
  • Child
  • Cross-Sectional Studies
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Male
  • Papillomaviridae
  • Papillomavirus Infections* / complications
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines*
  • Parents
  • Patient Acceptance of Health Care
  • Surveys and Questionnaires
  • Vaccination

Substances

  • Papillomavirus Vaccines

Grants and funding

This study has been funded and sponsored by MSD Spain.